Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation-Reference-Cited by-同舟云学术

Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation

Published:2017-01-06 Issue:8 Volume:8 Page:13413-13427
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ji Yanlong¹²,Wei Shasha¹²,Hou Junjie³,Zhang Chengqian¹²,Xue Peng¹,Wang Jifeng¹,Chen Xiulan¹,Guo Xiaojing¹,Yang Fuquan¹²

Affiliation:

1. Laboratory of Protein and Peptide Pharmaceuticals and Laboratory of Proteomics, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the synergistic effect mechanism underlying sequential use of palbociclib and cisplatin through integral proteomic and glycoproteomic analysis;Anti-Cancer Drugs;2024-07-08

2. Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis;Frontiers in Molecular Biosciences;2023-01-19

3. Glycoproteomics;Nature Reviews Methods Primers;2022-06-23

4. Role of the Mosaic Cisternal Maturation Machinery in Glycan Synthesis and Oncogenesis;Frontiers in Cell and Developmental Biology;2022-04-06

5. Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis;Frontiers in Pharmacology;2021-12-22